iodixanol has been researched along with Diabetic Nephropathies in 6 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shema-Didi, L | 1 |
| Kristal, B | 1 |
| Eizenberg, S | 1 |
| Marzuq, N | 1 |
| Sussan, M | 1 |
| Feldman-Idov, Y | 1 |
| Ofir, P | 1 |
| Atar, S | 1 |
| Rudnick, MR | 1 |
| Davidson, C | 2 |
| Laskey, W | 2 |
| Stafford, JL | 1 |
| Sherwin, PF | 1 |
| Aspelin, P | 1 |
| Rudnick, M | 1 |
| Aubry, P | 1 |
| Kumar, S | 1 |
| Gietzen, F | 1 |
| Wiemer, M | 1 |
| Solomon, R | 1 |
| Deray, G | 1 |
| Anselmino, M | 1 |
| Biondi-Zoccai, G | 1 |
| Sheiban, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title.[NCT00209430] | Phase 4 | 408 participants | Interventional | 2005-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for iodixanol and Diabetic Nephropathies
| Article | Year |
|---|---|
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary A | 2016 |
Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Topics: Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabeti | 2008 |
Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Diabetic Nephropathies; Double-Blind Method; | 2009 |
3 other studies available for iodixanol and Diabetic Nephropathies
| Article | Year |
|---|---|
Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Topics: Chronic Disease; Contrast Media; Coronary Angiography; Diabetic Nephropathies; Humans; Inpatients; I | 2010 |
Iodixanol and chronic kidney disease.
Topics: Chronic Disease; Contrast Media; Diabetic Nephropathies; Humans; Kidney Diseases; Triiodobenzoic Aci | 2006 |
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Topics: Angioplasty, Balloon, Coronary; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiogr | 2008 |